Weight Loss Programs & Treatments Our medical providers know that many contributing factors affect a patients ability to lose and keep weight off
If we get involved, are we encouraging risky behavior or practicing harm reduction
Pharmacoepidemiological studies using large healthcare databases have found associations between GLP-1 agonist use and reduced rates of alcohol-related hospitalizations, emergency department visits, and new diagnoses of alcohol use disorder
Steady, Controlled Release Oral supplements deliver a large dose of nutrients all at once, which can cause spikes in their effectiveness followed by a sharp decline
Moreover, only 54% of patients in those economics have access to oral cysteamine therapy, and there is limited access to cysteamine eye drops, supportive therapies, and standard diagnostic and monitoring tools, all of which are essential for the prevention of disease progression and extended lifespan [159]
Most doctors will recommend that candidates try other weight management approaches first before prescribing GLP-1 therapy